Final-Program-ATS-2023-AP.vp

SATURDAY • MAY 20

25

1:45 Incorporating Echocardiography Into CPR S. Cha, MD, Baltimore, MD 2:15 Break 2:30 Practical Skills Session: Hands-On Station IV Abdominal Ultrasound

Objectives At the conclusion of this session, the participant will be able to: • discuss how to interpret clinical guidelines recommendations • identify adults and children with asthma in whom monoclonal anti-IL5 antibody, omalizumab, tiotropium, and macrolides are indicated • describe a NIH clinical trial testing personalized treatment options for severe asthma This session will provide a comprehensive, pragmatic overview of the latest guidelines for severe asthma management from GINA, the NAEPP and ATS/ERS, with a particular focus on how they can be incorporated into practice. Course faculty are experts involved the creation of these guidelines. The course will incorporate interactive case-based review and panel discussion. Chairing: P. Akuthota, MD, ATSF, La Jolla, CA M. Kraft, MD, ATSF, New York, NY B.D. Medoff, MD, Boston, MA 8:00 How Should I Interpret the ERS/ATS Severe Asthma Guidelines? A. Bush, MD, ATSF, London, United Kingdom 8:30 Anti-Eosinophil and Anti-IL-4/IL-13 Therapies in Severe Asthma: What Do the Guidelines Say? M. Castro, MD, MPH, Kansas City, KS 9:00 Omalizumab in Severe Asthma: Where Does It Fit In Now? A. Bush, MD, ATSF, London, United Kingdom 9:30 Case-Based Panel Discussion M. Kraft, MD, ATSF, New York, NY 9:50 Break 10:05 Long-Acting Muscarinic Antagonists: Good for All With Severe Asthma? P. Akuthota, MD, ATSF, La Jolla, CA 10:35 Macrolides in Severe Asthma: Underutilized in the Age of Biologics? P.B. Gibson, MBBS, Newcastle, Australia 11:05 Frontiers in Clinical Trial Designs in Severe Asthma L.C. Denlinger, MD, PhD, Madison, WI 11:35 Case-Based Panel Discussion P. Akuthota, MD, ATSF, La Jolla, CA 11:55 Lunch 12:35 GINA and NAEPP Guidelines: Differences, Similarities, and Implementation Challenges J.A. Krishnan, MD, PhD, ATSF, Chicago, IL 1:05 Break 1:15 Severe Asthma Case Discussion N.L. Lugogo, MD, Ann Arbor, MI 3:15 Panel Discussion with Guideline Co-Chairs B.D. Medoff, MD, Boston, MA

D.A. Sweeney, MD, La Jolla, CA Z. Shaman, MD, Cleveland, OH D. Pradhan, MD, ATSF, New York, NY S. Sarzynski, MD, MHSc, Bethesda, MD G.B. Allen, MD, Burlington, VT

S. Cha, MD, Baltimore, MD Echo in Shock and CPR C. Bennett, DO, Rochester, MN T. Brakke, MD, Omaha, NE

L. Rapoport, MD, MS, Santa Clara, CA A. Sarwal, MD, Winston-Salem, NC S. Bain, MD, Seattle, WA J.E. Pittman, MD, Salt Lake City, UT Ask the Expert A. Leibowitz, MD, Boston, MA X. Monnet, MD, PhD, Le Kremlin-Bicêtre, France N. Panebianco, MD, MPH, Philadelphia, PA

J. Kasal, MD, St. Louis, MO J.C. Klick, MD, Burlington, VT P.K. Mohabir, MD, Stanford, CA This session and the International Conference are supported by In-Kind grants from EchoNous, GE HealthCare, FUJIFILM Sonosite, Teleflex. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).

CLINICAL POSTGRADUATE COURSE CME Credits Available: 7

PG5 SEVERE ASTHMA 2023: IMPLEMENTING CURRENT GUIDELINES INTO PRACTICE R Pre-registration and additional fees required. Attendance is limited. Member: $440 In-Training Member: $255 LMIC Member: $310 LMIC In-Training Member: $180 Non-Member: $540 In-Training Non-Member: $380 Assemblies on Allergy, Immunology and Inflammation 8:00 AM - 4:00 PM Marriott Marquis Washington Archives (Level M4) Target Audience Pulmonary and allergy physicians, physicians in training, and advanced practice providers who care for patients with asthma.

ATS 2023 • Washington, DC